Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Common Stock
IPO
Common Stock
Private Placement
Common Stock
Preferred Stock
Treasury Stock
Additional Paid-in Capital
IPO
Additional Paid-in Capital
Private Placement
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive (Loss) Income Net of Income Taxes
IPO
Private Placement
Total
Balance at Dec. 31, 2020     $ 140 $ 610 $ (260,686)     $ 620,679 $ 54,941 $ 1,011     $ 416,695
Balance (in shares) at Dec. 31, 2020     140,222 61,006 15,146                
Foreign currency translation adjustment                   (799)     (799)
Stock-based compensation expense               2,538         2,538
Common stock issued upon exercise of stock options               538         538
Common stock issued upon exercise of stock options (in shares)     180                    
Net Income (loss)                 5,644       5,644
Balance at Mar. 31, 2021     $ 140 $ 610 $ (260,686)     623,755 60,585 212     424,616
Balance (in shares) at Mar. 31, 2021     140,402 61,006 15,146                
Balance at Dec. 31, 2020     $ 140 $ 610 $ (260,686)     620,679 54,941 1,011     416,695
Balance (in shares) at Dec. 31, 2020     140,222 61,006 15,146                
Foreign currency translation adjustment                         (141)
Net Income (loss)                         1,000
Balance at Sep. 30, 2021     $ 159   $ (1,802)     677,588 55,941 870     732,756
Balance (in shares) at Sep. 30, 2021     158,524   50                
Balance at Mar. 31, 2021     $ 140 $ 610 $ (260,686)     623,755 60,585 212     424,616
Balance (in shares) at Mar. 31, 2021     140,402 61,006 15,146                
Foreign currency translation adjustment                   355     355
Stock-based compensation expense               4,714         4,714
Common stock issued $ 10 $ 1       $ 269,380 $ 29,999       $ 269,390 $ 30,000  
Common stock issued (in shares) 9,977 1,111                      
Common stock issued upon exercise of stock options     $ 2         2,907         2,909
Common stock issued upon exercise of stock options (in shares)     871                    
Common stock issued upon vesting of restricted stock units (in shares)     217                    
Conversion of Series A preferred stock to common stock     $ 5 $ (610) $ 260,686     (260,081)          
Conversion of Series A preferred stock to common stock (in shares)     5,190 (61,006) (15,146)                
Net Income (loss)                 (12,568)       (12,568)
Balance at Jun. 30, 2021     $ 158         670,674 48,017 567     719,416
Balance (in shares) at Jun. 30, 2021     157,768                    
Foreign currency translation adjustment                   303     303
Shares repurchased for settlement of employee tax withholdings         $ (1,802)               (1,802)
Shares repurchased for settlement of employee tax withholdings (in shares)         50                
Stock-based compensation expense               4,848         4,848
Common stock issued upon exercise of stock options     $ 1         2,066         2,067
Common stock issued upon exercise of stock options (in shares)     651                    
Common stock issued upon vesting of restricted stock units (in shares)     105                    
Net Income (loss)                 7,924       7,924
Balance at Sep. 30, 2021     $ 159   $ (1,802)     677,588 55,941 870     732,756
Balance (in shares) at Sep. 30, 2021     158,524   50                
Balance at Dec. 31, 2021     $ 162   $ (1,802)     717,228 84,249 (771)     799,066
Balance (in shares) at Dec. 31, 2021     162,347   50                
Foreign currency translation adjustment                   (1,570)     (1,570)
Shares repurchased for settlement of employee tax withholdings         $ (1,058)               (1,058)
Shares repurchased for settlement of employee tax withholdings (in shares)         41                
Stock-based compensation expense               10,994         10,994
Common stock issued (in shares)     4                    
Common stock issued upon exercise of stock options     $ 1         1,677         1,678
Common stock issued upon exercise of stock options (in shares)     572                    
Common stock issued upon vesting of restricted stock units (in shares)     195                    
Net Income (loss)                 4,579       4,579
Balance at Mar. 31, 2022     $ 163   $ (2,860)     729,899 88,828 (2,341)     813,689
Balance (in shares) at Mar. 31, 2022     163,118   91                
Balance at Dec. 31, 2021     $ 162   $ (1,802)     717,228 84,249 (771)     799,066
Balance (in shares) at Dec. 31, 2021     162,347   50                
Foreign currency translation adjustment                         $ (11,834)
Common stock issued upon exercise of stock options (in shares)                         1,303
Net Income (loss)                         $ 25,200
Balance at Sep. 30, 2022     $ 165   $ (1,002)     744,008 109,449 (12,605)     840,015
Balance (in shares) at Sep. 30, 2022     164,733   37                
Balance at Mar. 31, 2022     $ 163   $ (2,860)     729,899 88,828 (2,341)     813,689
Balance (in shares) at Mar. 31, 2022     163,118   91                
Foreign currency translation adjustment                   (5,634)     (5,634)
Shares repurchased for settlement of employee tax withholdings         $ (8,133)               (8,133)
Shares repurchased for settlement of employee tax withholdings (in shares)         320                
Stock-based compensation expense               9,517         9,517
Common stock issued under employee purchase plan               768         768
Common stock issued under employee purchase plan (in shares)     41                    
Common stock issued upon exercise of stock options               838         838
Common stock issued upon exercise of stock options (in shares)     176                    
Common stock issued upon vesting of restricted stock units     $ 1         (1)          
Common stock issued upon vesting of restricted stock units (in shares)     798                    
Treasury stock reissued upon settlement of equity awards         $ 3,447     (3,447)          
Treasury stock reissued upon settlement of equity awards (in shares)         (128)                
Net Income (loss)                 10,290       10,290
Balance at Jun. 30, 2022     $ 164   $ (7,546)     737,574 99,118 (7,975)     821,335
Balance (in shares) at Jun. 30, 2022     164,133   283                
Foreign currency translation adjustment                   (4,630)     (4,630)
Shares repurchased for settlement of employee tax withholdings         $ (492)               (492)
Shares repurchased for settlement of employee tax withholdings (in shares)         19                
Stock-based compensation expense               11,080         11,080
Common stock issued upon exercise of stock options     $ 1         2,390         2,391
Common stock issued upon exercise of stock options (in shares)     490                    
Common stock issued upon vesting of restricted stock units (in shares)     110                    
Treasury stock reissued upon settlement of equity awards         $ 7,036     (7,036)          
Treasury stock reissued upon settlement of equity awards (in shares)         (265)                
Net Income (loss)                 10,331       10,331
Balance at Sep. 30, 2022     $ 165   $ (1,002)     $ 744,008 $ 109,449 $ (12,605)     $ 840,015
Balance (in shares) at Sep. 30, 2022     164,733   37